Cargando…

HIV Positive Status Disclosure and Its Associated Factors Among Children on Antiretroviral Therapy in West Shoa Zone, Western Ethiopia, 2019: A Mixed Method Cross-Sectional Study

BACKGROUND: Evidence from previous studies supports the idea that informing children about their HIV status has long-term positive implications in HIV disease management, children’s quality of life, and ART drug adherence. However, in sub-Saharan African Countries, the HIV status disclosure among ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Shallo, Seifadin Ahmed, Tassew, Mesfin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305934/
https://www.ncbi.nlm.nih.gov/pubmed/32606722
http://dx.doi.org/10.2147/JMDH.S258851
_version_ 1783548569571033088
author Shallo, Seifadin Ahmed
Tassew, Mesfin
author_facet Shallo, Seifadin Ahmed
Tassew, Mesfin
author_sort Shallo, Seifadin Ahmed
collection PubMed
description BACKGROUND: Evidence from previous studies supports the idea that informing children about their HIV status has long-term positive implications in HIV disease management, children’s quality of life, and ART drug adherence. However, in sub-Saharan African Countries, the HIV status disclosure among children ranges from 0% to 69.2%. So it is important to investigate the up to date evidence that will help in designing contextualized approaches for disclosure. Therefore, this study aimed to assess the HIV status disclosure and its associated factors among children on ART in West Shoa Zone, Ethiopia. MATERIALS AND METHODS: Institutional-based observational study was conducted from February to April 2019. Quantitative data were collected from a randomly selected sample of 247 HIV positive children on ART for the last six months, and the qualitative data were collected from caregivers and health care professionals. RESULTS: The mean age of the children was 11.11±SD2.8, and 43.6%, (95% CI: 37, 50.9) of the children were fully disclosed. The average age at disclosure was 11±SD2.12. The main reasons for the disclosure were for drug adherence and better self-care while being underage was the commonest reason for non-disclosure. Compared to the age 10–15 years, the child in the age 6–9 was 97% [AOR: 0.027, 95% CI: 0.003, 0.22, P<0.001] less likely to be disclosed. Female children were 2.7 times more likely to be disclosed compared with male children [AOR: 2.73, 95% CI: 1.24, 6, P<0.013]. CONCLUSION: This finding reveals that HIV status disclosure is generally low, and the decision to disclose or not is affected by factors like child-related, caregivers, and health institution-related factors. This may affect the child’s drug adherence, treatment outcome, and disease transmission. Updating health care providers’ knowledge and skills and working on caregivers’ attitude are needed to manage disclosure and challenges following it.
format Online
Article
Text
id pubmed-7305934
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73059342020-06-29 HIV Positive Status Disclosure and Its Associated Factors Among Children on Antiretroviral Therapy in West Shoa Zone, Western Ethiopia, 2019: A Mixed Method Cross-Sectional Study Shallo, Seifadin Ahmed Tassew, Mesfin J Multidiscip Healthc Original Research BACKGROUND: Evidence from previous studies supports the idea that informing children about their HIV status has long-term positive implications in HIV disease management, children’s quality of life, and ART drug adherence. However, in sub-Saharan African Countries, the HIV status disclosure among children ranges from 0% to 69.2%. So it is important to investigate the up to date evidence that will help in designing contextualized approaches for disclosure. Therefore, this study aimed to assess the HIV status disclosure and its associated factors among children on ART in West Shoa Zone, Ethiopia. MATERIALS AND METHODS: Institutional-based observational study was conducted from February to April 2019. Quantitative data were collected from a randomly selected sample of 247 HIV positive children on ART for the last six months, and the qualitative data were collected from caregivers and health care professionals. RESULTS: The mean age of the children was 11.11±SD2.8, and 43.6%, (95% CI: 37, 50.9) of the children were fully disclosed. The average age at disclosure was 11±SD2.12. The main reasons for the disclosure were for drug adherence and better self-care while being underage was the commonest reason for non-disclosure. Compared to the age 10–15 years, the child in the age 6–9 was 97% [AOR: 0.027, 95% CI: 0.003, 0.22, P<0.001] less likely to be disclosed. Female children were 2.7 times more likely to be disclosed compared with male children [AOR: 2.73, 95% CI: 1.24, 6, P<0.013]. CONCLUSION: This finding reveals that HIV status disclosure is generally low, and the decision to disclose or not is affected by factors like child-related, caregivers, and health institution-related factors. This may affect the child’s drug adherence, treatment outcome, and disease transmission. Updating health care providers’ knowledge and skills and working on caregivers’ attitude are needed to manage disclosure and challenges following it. Dove 2020-06-16 /pmc/articles/PMC7305934/ /pubmed/32606722 http://dx.doi.org/10.2147/JMDH.S258851 Text en © 2020 Shallo and Tassew. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Shallo, Seifadin Ahmed
Tassew, Mesfin
HIV Positive Status Disclosure and Its Associated Factors Among Children on Antiretroviral Therapy in West Shoa Zone, Western Ethiopia, 2019: A Mixed Method Cross-Sectional Study
title HIV Positive Status Disclosure and Its Associated Factors Among Children on Antiretroviral Therapy in West Shoa Zone, Western Ethiopia, 2019: A Mixed Method Cross-Sectional Study
title_full HIV Positive Status Disclosure and Its Associated Factors Among Children on Antiretroviral Therapy in West Shoa Zone, Western Ethiopia, 2019: A Mixed Method Cross-Sectional Study
title_fullStr HIV Positive Status Disclosure and Its Associated Factors Among Children on Antiretroviral Therapy in West Shoa Zone, Western Ethiopia, 2019: A Mixed Method Cross-Sectional Study
title_full_unstemmed HIV Positive Status Disclosure and Its Associated Factors Among Children on Antiretroviral Therapy in West Shoa Zone, Western Ethiopia, 2019: A Mixed Method Cross-Sectional Study
title_short HIV Positive Status Disclosure and Its Associated Factors Among Children on Antiretroviral Therapy in West Shoa Zone, Western Ethiopia, 2019: A Mixed Method Cross-Sectional Study
title_sort hiv positive status disclosure and its associated factors among children on antiretroviral therapy in west shoa zone, western ethiopia, 2019: a mixed method cross-sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305934/
https://www.ncbi.nlm.nih.gov/pubmed/32606722
http://dx.doi.org/10.2147/JMDH.S258851
work_keys_str_mv AT shalloseifadinahmed hivpositivestatusdisclosureanditsassociatedfactorsamongchildrenonantiretroviraltherapyinwestshoazonewesternethiopia2019amixedmethodcrosssectionalstudy
AT tassewmesfin hivpositivestatusdisclosureanditsassociatedfactorsamongchildrenonantiretroviraltherapyinwestshoazonewesternethiopia2019amixedmethodcrosssectionalstudy